•  
  •  
  •  
  •  

2026-02-17 01:22:41

  • Home
  • Commodities
  • Industry News
  • IPO
  • Mutual Funds
  • Others
  • Research
  • Watch List
Latest News
  • Texmaco Rail & Engineering Ltd receives order worth Rs. 219.18 crores
  • HFCL secures Purchase Orders worth ~INR 60.95 crore for supply of Optical Fiber Cables
  • Highway Infrastructure Ltd receives LoA of Rs. 154.59 crores
  • EKI Energy Services Ltd featured among Top Global Renewable Energy Carbon Credit Suppliers in Abatable's 2026 Carbon Market Report
  • Shraddha Prime Projects Ltd to enter into Development Agreement for new project

Keywords Selected:  Pharmaceuticals

Research

  • CRISIL: Pharmaceutical sector set for 8-10% revenue growth this fiscal
  • Kotak Institutional Equities - Pharmaceuticals: IPM pulse - gaining momentum
  • Company Update - P&G Health - ICICI Direct
  • Quant Pick - Cadila Healthcare - ICICI Direct
  • Q2FY22 Result Update - Syngene International - ICICI Direct
  • Syngene International Ltd - Lack of near term triggers - YES Securities
  • Syngene International Ltd - Lower gross margin lead to EBIDTA miss - YES Securities

IPO News

  • Accretion Pharmaceuticals' IPO Opens for subscription today, Price Band set at ₹96-101 per Share
  • Accretion Pharmaceuticals Ltd IPO to open for subscription on May 14, 2025
  • Senores Pharmaceuticals IPO subscribed 13.93 times on Day 2
  • Senores Pharmaceuticals IPO fully subscribed on Day 1
  • Senores Pharmaceuticals gets Sebi nod for IPO

Stock Report

  • Lupin signs License and Supply Agreement with Spektus to Commercialize Novel Antidepressant DeslaFlex™ in Canada
  • USFDA inspection at the manufacturing facility of Enzene Biosciences Limited
  • Mankind Pharma Reinvents Global Supply Chain and Procurement with Accenture
  • Ind-Swift Laboratories allocates ₹40 Cr for Samba Facility Upgrade
  • Eris delivers 10% YoY growth in DBF business and 11% in consolidated revenue during Q3 FY26
  • Akums delivers strong Q3 FY26 performance with 14.8% revenue growth and 21% Adj EBITDA growth
  • Supriya Lifescience Delivers Strong Q3 FY26 Results with 11% YoY Revenue Growth
  • Zydus Lifesciences Q3 & 9M FY26: Revenue +30% YoY to ₹686 Cr (Q3), EBITDA +31% at 27%; Net Debt/EBITDA 0.36x
  • Wanbury Limited Q3 FY26: PAT Explodes 1,194% YoY to ₹15.8 Cr, Revenue Up 22%
  • Alembic Pharmaceuticals gets USFDA nod for generic Parkinson's disease treatment tablets
  • Zydus receives USFDA Orphan Drug Designation (ODD) for Desidustat for the treatment of Sickle Cell Disease
  • Zydus receives tentative approval from USFDA for Dapagliflozin Tablets, 5 mg and 10 mg
  • NATCO receives Tentative Approval for Erdafitinib Tablets from USFDA
  • SPARC announces receipt of Priority Review Voucher associated with Sezaby® Approval
  • Hester receives manufacturing license for Inactivated Avian Influenza Vaccine for poultry
  • Asston Pharmaceuticals Ltd commences commercial production at Unit 2
  • CORONA Remedies Ltd secures Prestigious EAEU-GMP Certification, Strengthening Global Presence
  • Jagsonpal Pharmaceuticals Ltd Q3FY26 profit at Rs. 10.95 crores
  • Lupin and Galenicum Sign License and Supply Agreement for Semaglutide in 23 Countries
  • Senores Pharmaceuticals Ltd consolidated Q3FY26 profit at Rs. 33.58 crores
  • Syngene International extends long-term research collaboration with Bristol Myers Squibb until 2035
  • JB Chemicals & Pharmaceuticals Ltd records revenue growth of 11% to INR 1065 crores in Q3 FY26
  • Medicamen Biotech Ltd gets EU approval for Paracetamol from Danish Medicine Authority
  • Gland Pharma receives approval for Olopatadine Hydrochloride Ophthalmic Solution USP, 0.7% (OTC)

Industry News

  • NYSE Listed Amneal Pharmaceuticals begins Commercial Operations in India

Latest Post

  • Texmaco Rail & Engineering Ltd receives order worth Rs. 219.18 crores
  • HFCL secures Purchase Orders worth ~INR 60.95 crore for supply of Optical Fiber Cables
  • Highway Infrastructure Ltd receives LoA of Rs. 154.59 crores
  • EKI Energy Services Ltd featured among Top Global Renewable Energy Carbon Credit Suppliers in Abatable's 2026 Carbon Market Report
  • Shraddha Prime Projects Ltd to enter into Development Agreement for new project


Announcement

To Advertise in our website please e-mail us at advertisement@equitybulls.com
Companies can send their Press Releases to pressrelease@equitybulls.com

Links

  • Home
  • Contact
  • Our Team

Contact

The website is developed and maintained by Chennai Scripts
C-4, Podhigai Flats, Pillayar Koil Street, Nesapakkam
Chennai
Tamil Nadu
India
600078
E-mail: chennaiscripts@gmail.com
Mobile Phone Number: +91-88776-69935
www.chennaiscripts.com

Website Created & Maintained by : Chennai Scripts
Nesapakkam, Chennai - 600 078,
Tamil Nadu, India

Disclaimer Copyright © - 2025